EAGLE ASSET MANAGEMENT INC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
EAGLE ASSET MANAGEMENT INC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$21,972,792
+3.8%
575,204
-2.0%
0.13%
+10.2%
Q2 2023$21,175,723
-30.5%
587,073
-26.5%
0.12%
-33.7%
Q1 2023$30,489,000
-48.3%
798,362
-25.4%
0.18%
-50.8%
Q4 2022$58,988,000
+12.6%
1,069,991
-19.2%
0.36%
+5.8%
Q3 2022$52,391,000
-14.6%
1,325,019
-5.0%
0.34%
-11.2%
Q2 2022$61,368,000
+28.4%
1,394,737
+16.4%
0.38%
+57.1%
Q1 2022$47,780,000
-5.7%
1,198,107
-4.7%
0.24%
+10.4%
Q4 2021$50,663,000
-15.1%
1,256,542
-14.4%
0.22%
-17.5%
Q3 2021$59,681,000
-22.6%
1,467,088
-13.6%
0.27%
-18.7%
Q2 2021$77,085,000
+2.5%
1,697,542
-4.2%
0.33%
-0.6%
Q1 2021$75,185,000
-5.4%
1,772,000
-4.8%
0.33%
-25.7%
Q4 2020$79,469,000
+40.2%
1,860,706
-13.0%
0.45%
+53.4%
Q3 2020$56,697,000
+4.0%
2,138,721
+1.3%
0.29%
-5.8%
Q2 2020$54,502,000
+43.3%
2,110,871
-0.1%
0.31%
+30.8%
Q1 2020$38,027,000
+40.0%
2,113,788
+38.0%
0.24%
+80.9%
Q4 2019$27,164,000
+13.7%
1,532,141
-0.6%
0.13%
+6.5%
Q3 2019$23,894,0001,540,6160.12%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders